Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Lupin has received final approval from the Food and Drug Administration (FDA) for Kaitlib Fe Chewable Tablets (norethindrone/ethinyl estradiol and ferrous fumarate), the generic version of Warner Chilcott’s Generess Fe Chewable Tablets.
Generess Fe is a progestin and estrogen combination contraceptive indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
RELATED: The Pill Does Not Up Birth Defects Risk, Study Finds
Kaitlib Fe will be available as 0.8mg/0.025mg norethindrone acetate/ethinyl estradiol with 75mg ferrous fumarate chewable tablets. It will be supplied in 3 x 28 blister packs.
For more information call (800) 399-2561 or visit Lupinpharmaceuticals.com.
Related Content
